Pyxis Oncology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Pyxis Oncology, Inc. (PYXS) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 1.28 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.28M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.51M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.63M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.80M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2026-06-30 | 1.28M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 1.51M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 1.63M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 1.80M shares 10-Q · filed 2025-11-03 | |
| 2025-06-30 | 1.94M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 2.42M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 2.53M shares 10-K · filed 2026-03-23 | 2.46M shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 2.99M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 3.05M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 3.11M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 3.63M shares 10-K · filed 2025-03-18 | |
| 2023-09-30 | 3.82M shares 10-Q · filed 2023-11-07 | |
| 2023-06-30 | 3.80M shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 5.75M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 3.02M shares 10-K · filed 2024-03-21 | |
| 2022-09-30 | 3.12M shares 10-Q · filed 2022-11-01 | |
| 2022-06-30 | 2.96M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 2.60M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 618.49K shares 10-K · filed 2023-03-22 | |
| 2021-09-30 | 554.72K shares 10-Q · filed 2021-11-15 | |
| 2020-12-31 | 888.61K shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |